The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $115.04

Today's change-0.97 -0.84%
Updated July 2 4:00 PM EDT. Delayed by at least 15 minutes.
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $115.04

Today's change-0.97 -0.84%
Updated July 2 4:00 PM EDT. Delayed by at least 15 minutes.

Gilead Sciences Inc down (U.S.)$0.97

Gilead Sciences Inc closed lower Thursday, dropping (U.S.)$0.97 or 0.84% to (U.S.)$115.04. Shares have lost 4.32% over the last five days, but have gained 22.05% over the last year to date. This security has outperformed the S&P 500 by 26.90% during the last year.

Key company metrics

  • Open(U.S.) $116.33
  • Previous close(U.S.) $116.01
  • High(U.S.) $116.49
  • Low(U.S.) $114.91
  • Bid / Ask-- / --
  • YTD % change+22.05%
  • Volume8,831,970
  • Average volume (10-day)10,706,722
  • Average volume (1-month)10,502,819
  • Average volume (3-month)10,904,339
  • 52-week range(U.S.) $84.75 to (U.S.) $123.37
  • Beta0.79
  • Trailing P/E13.07×
  • P/E 1 year forward10.68×
  • Forward PEG0.86×
  • Indicated annual dividend(U.S.) $1.72
  • Dividend yield1.50%
  • Trailing EPS(U.S.) $8.80
Updated July 2 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+51.55%

Based on its net profit margin of 51.55%, Gilead Sciences Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.30%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue7,5947,3146,0426,535
Total other revenue--------
Total revenue7,5947,3146,0426,535
Gross profit6,7116,2515,0555,610
Total cost of revenue8831,063987925
Total operating expense2,2232,9842,5632,122
Selling / general / administrative643876945614
Research & development6941,045630584
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)3------
Other operating expenses, total--------
Operating income5,3714,3303,4794,413
Interest income (expense), net non-operating-153-130-103-102
Gain (loss) on sale of assets--------
Other--------
Income before tax5,2394,2303,3714,307
Income after tax4,3323,4622,7243,650
Income tax, total907768647657
Net income4,3333,4872,7313,656
Total adjustments to net income--------
Net income before extra. items4,3333,4872,7313,656
Minority interest12575
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items4,3333,4872,7313,656
Inc. avail. to common incl. extra. items4,3333,4872,7313,656
Diluted net income4,3333,4872,7313,656
Dilution adjustment--------
Diluted weighted average shares1,5691,6011,6371,664
Diluted EPS excluding extraordinary itemsvalue per share2.762.181.672.20
Dividends per sharevalue per share0.430.000.000.00
Diluted normalized EPSvalue per share2.762.181.672.20